$82.97
0.210.25%
Pre-Market: Nov 13, 6:56 PM EDT
Comments
Loading...
Belite Bio (BLTE) Forecast
NewsEarningsBelite Bio (BLTE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBelite Bio (NASDAQ:BLTE) Stock Quotes, Forecast and News Summary
Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Belite Bio (BLTE) stock?
You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.
Who are Belite Bio (BLTE) competitors?
Other companies in Belite Bio’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
What is the forecast, or price target, for Belite Bio (BLTE) stock?
Belite Bio has a consensus price target of $73.00.
What is the current price for Belite Bio (BLTE)?
The stock price for Belite Bio (NASDAQ: BLTE) is $82.97 last updated November 13, 2024 at 6:56 PM EST.
Does Belite Bio (BLTE) pay a dividend?
There are no upcoming dividends for Belite Bio.
When is Belite Bio (NASDAQ:BLTE) reporting earnings?
Belite Bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Belite Bio (BLTE) going to split?
There is no upcoming split for Belite Bio.
What sector and industry does Belite Bio (BLTE) operate in?
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.